Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Genital Herpes
NCT03831165Phase 4Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Sep 2015
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of melatonin in genital herpes (3 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Clinical disease activity at 2 years. Started Sep 2015; status: completed.
02
Drugs
melatonin
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT03831165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03831165.